10x Genomics (NASDAQ:TXG) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their ...

This workshop explored current and potential future applications for AI in genomics and precision health along the continuum from translational research to clinical applications. A planning committee ...

Many of today's most advanced tools in medicine are not designed for the real-world clinical environments where most of the global population receives care. Vignesh Bageerathan, a genomics innovator ...

The era of predictive genomics is rapidly reshaping how we think about disease, risk and lifelong health. Recent advances in whole-genome sequencing have equipped clinicians with insights into our ...

The past decade has delivered landmark advances in human and medical genomics that shape how we understand disease mechanisms ...

A genomics pioneer over the last 25 years, diagnosing more than 4,800 genetic diseases and publishing more than 1,000 research publications, GeneDx is building the network that will drive the future ...

In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human whole genome sequencing has been set. Think of all the things that can be done in four ...

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights today announced Linda Genen, MD, MPH as Chief Medical Officer to further strengthen the company’s ...